Publication:
Effects of Recombinant Activated Protein C Derived From Drotrecogin-Alpha on Bleomycin-Induced Pulmonary Fibrosis in Rats Compared with Methyl-Prednisolone

Loading...
Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

Yildiz, Kadir

Iraz, Mustafa

ŞAMDANCI, EMİNE

ÖZEROL, ELİF

KUKU, İRFAN

AYTEMUR, ZEYNEP AYFER

HACIEVLİYAGİL, SÜLEYMAN SAVAŞ

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

OBJECTIVE: In this study, we aimed to test the preventive effects of intraperitoneally administered drotrecogin alpha which is derived from activated protein C (APC), on bleomycin-induced pulmonary fibrosis in rats, and to compare the effects of APC with the effects of methyl-prednisolone, a traditional therapy.

Description

Source

Keywords

Keywords

Citation

Yildiz K., Iraz M., ŞAMDANCI E., ÖZEROL E., KUKU İ., AYTEMUR Z. A. , HACIEVLİYAGİL S. S. , -Effects of Recombinant Activated Protein C Derived From Drotrecogin-Alpha on Bleomycin-Induced Pulmonary Fibrosis in Rats Compared with Methyl-Prednisolone-, TURKISH THORACIC JOURNAL, cilt.14, ss.48-52, 2013

Endorsement

Review

Supplemented By

Referenced By

2

Views

0

Downloads

View PlumX Details


Sustainable Development Goals